A Medicament for Treating Inflammation by Inhibiting Transactivation and Translocation of NF-ΚB
The present invention disclosed a medicament comprising nickel (II) complex represented by Formula or its pharmaceutically acceptable salts, prodrug and solvates thereof for treating inflammation by inhibiting transactivation and translocation of nuclear factor-kappa-light-chain-enhancer of activated B cells, NF-KB.
Contact person for this offer:
ChM Dr. Lee Ching Shya, PhD (Dual), RTTP
Technology Transfer Manager
Tel: +603-7967-7351/ 013-2250151